Allergic Reactions to Human Insulin: a Review of Current Knowledge and Treatment Options

Overview

Journal Endocrine

Specialty Endocrinology

Date 2009 Oct 31

PMID 19876775

Citations 11

Authors

Baris Akinci

Serkan Yener

Firat Bayraktar

Sena Yesil

Affiliations

Soon will be listed here.

Abstract

Although the incidence of insulin allergy decreased after the introduction of recombinant human insulin preparations, it is still a major problem which may be life-threatening in some cases. In this article, we attempted to review current knowledge concerning allergic reactions to human insulin and discuss the available treatment options of insulin allergy.

Citing Articles

Levels of anti-insulin antibodies in diabetic retinopathy patients: an observational cross-sectional study.

Mohammed B, Ofori E, Adekena C, Amponsah S, Asare-Anane H, Amanquah S Future Sci OA. 2024; 10(1):FSO982.

PMID: 38817369 PMC: 11137838. DOI: 10.2144/fsoa-2024-0002.

Insulin Glargine Associated Nausea in a Patient Seen by a Collaborative Drug Therapy Management Pharmacist in an Urban Community Hospital: A Case Report.

Gerber A, Quinn R Hosp Pharm. 2024; 59(1):15-18.

PMID: 38223864 PMC: 10786061. DOI: 10.1177/00185787231185868.

Insulin allergy: a diagnostic and therapeutic strategy based on a retrospective cohort and a case-control study.

Sola-Gazagnes A, Pecquet C, Berre S, Achenbach P, Pierson L, Virmoux-Buisson I Diabetologia. 2022; 65(8):1278-1290.

PMID: 35505238 DOI: 10.1007/s00125-022-05710-9.

Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus.

Clarke B, Loudovaris T, Radford T, Drogemuller C, Coates P, Torpy D Clin Case Rep. 2020; 8(12):2759-2762.

PMID: 33363817 PMC: 7752599. DOI: 10.1002/ccr3.3200.

Insulin allergy can be successfully managed by a systematic approach.

Haastrup M, Henriksen J, Mortz C, Bindslev-Jensen C Clin Transl Allergy. 2018; 8:35.

PMID: 30258565 PMC: 6154953. DOI: 10.1186/s13601-018-0223-x.

References

Blumer I . Severe injection site reaction to insulin detemir. Diabetes Care. 2006; 29(4):946. DOI: 10.2337/diacare.29.04.06.dc05-2503. View

Lindholm A, Jensen L, Home P, Raskin P, Boehm B, Rastam J . Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes. Diabetes Care. 2002; 25(5):876-82. DOI: 10.2337/diacare.25.5.876. View

Ratner R, Phillips T, Steiner M . Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes. 1990; 39(6):728-33. DOI: 10.2337/diab.39.6.728. View

Malaise J, Leonet J, Goffin E, Lefebvre C, Tennstedt D, Vandeleene B . Pancreas transplantation for treatment of generalized allergy to human insulin in type 1 diabetes. Transplant Proc. 2005; 37(6):2839. DOI: 10.1016/j.transproceed.2005.05.020. View

Sola-Gazagnes A, Pecquet C, MBemba J, Larger E, Slama G . Type I and type IV allergy to the insulin analogue detemir. Lancet. 2007; 369(9562):637-8. DOI: 10.1016/S0140-6736(07)60301-8. View

Eapen S, Connor E, Gern J . Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child. Ann Allergy Asthma Immunol. 2000; 85(5):395-7. DOI: 10.1016/S1081-1206(10)62554-9. View

Coll A, Thomas S, Mufti G . Rituximab therapy for the type B syndrome of severe insulin resistance. N Engl J Med. 2004; 350(3):310-1. DOI: 10.1056/NEJM200401153500324. View

Naf S, Esmatjes E, Recasens M, Valero A, Halperin I, Levy I . Continuous subcutaneous insulin infusion to resolve an allergy to human insulin. Diabetes Care. 2002; 25(3):634-5. DOI: 10.2337/diacare.25.3.634-a. View

Matheu V, Perez E, Hernandez M, Diaz E, Darias R, Gonzalez A . Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin. Clin Mol Allergy. 2005; 3:16. PMC: 1352375. DOI: 10.1186/1476-7961-3-16. View

10.

Sola-Gazagnes A, Pecquet C, Radermecker R, Pietri L, Elgrably F, Slama G . Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin. Diabetes Care. 2003; 26(10):2961-2. DOI: 10.2337/diacare.26.10.2961. View

11.

Adachi A, Fukunaga A, Horikawa T . A case of human insulin allergy induced by short-acting and intermediate-acting insulin but not by long-acting insulin. Int J Dermatol. 2004; 43(8):597-9. DOI: 10.1111/j.1365-4632.2004.02141.x. View

12.

Kara C, Oguz Kutlu A, Evliyaoglu O, Bilgili H, Yildirim N . Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin. Diabetes Care. 2005; 28(4):983-4. DOI: 10.2337/diacare.28.4.983. View

13.

Panczel P, Hosszufalusi N, Horvath M, Horvath A . Advantage of insulin lispro in suspected insulin allergy. Allergy. 2000; 55(4):409-10. DOI: 10.1034/j.1398-9995.2000.00565.x. View

14.

Grammer L . Insulin allergy. Clin Rev Allergy. 1986; 4(2):189-200. DOI: 10.1007/BF02991108. View

15.

Bodtger U, Wittrup M . A rational clinical approach to suspected insulin allergy: status after five years and 22 cases. Diabet Med. 2004; 22(1):102-6. DOI: 10.1111/j.1464-5491.2004.01352.x. View

16.

JiXiong X, Jianying L, Yulan C, Huixian C . The human insulin analog aspart can induce insulin allergy. Diabetes Care. 2004; 27(8):2084-5. DOI: 10.2337/diacare.27.8.2084-a. View

17.

Yong P, Malik R, Arif S, Peakman M, Amiel S, Ibrahim M . Rituximab and omalizumab in severe, refractory insulin allergy. N Engl J Med. 2009; 360(10):1045-7. DOI: 10.1056/NEJMc0808282. View

18.

Maislos M, Mead P, Gaynor D, Robbins D . The source of the circulating aggregate of insulin in type I diabetic patients is therapeutic insulin. J Clin Invest. 1986; 77(3):717-23. PMC: 423455. DOI: 10.1172/JCI112366. View

19.

Frigerio C, Aubry M, Gomez F, Graf L, Dayer E, de Kalbermatten N . Desensitization-resistant insulin allergy. Allergy. 1997; 52(2):238-9. DOI: 10.1111/j.1398-9995.1997.tb00988.x. View

20.

Schernthaner G . Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care. 1993; 16 Suppl 3:155-65. DOI: 10.2337/diacare.16.3.155. View